Keloids Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Sirnaomics, Yuhan Pharmaceuticals, Lemonex Inc., CellionBioMed

Keloids Pipeline constitutes 5+ key companies continuously working towards developing 5+ Keloids treatment therapies, analyzes DelveInsight.

Keloids Overview:

Keloids are a type of hypertrophic scar that extends beyond the original injury site, forming raised, irregular growths that do not regress over time. They commonly develop after skin trauma such as surgical incisions, burns, severe acne, or minor scratches. People with darker skin tones and a family history of keloids are more susceptible. These scars appear shiny and firm, with colors ranging from pink to dark brown and can cause itching, tenderness, or pain, especially when located over joints or high-movement areas.
Keloid formation results from excessive collagen production during wound healing, influenced by genetics, skin tension, and inflammatory responses. The imbalance in collagen synthesis and breakdown leads to the uncontrolled growth of scar tissue.
Diagnosis is clinical, based on the scar's appearance and history, though a biopsy may be used to rule out other conditions.
Treatment options focus on reducing size, alleviating symptoms, and preventing recurrence. Common treatments include:
Corticosteroid injections (to flatten and reduce inflammation)
Surgical removal (often combined with other therapies to lower recurrence risk)
Laser therapy & cryotherapy (to shrink and lighten keloids)
Silicone sheets & gels (to flatten and reduce discoloration)
Pressure or radiation therapy (for severe cases)
Prevention strategies include proper wound care, avoiding unnecessary skin trauma, and early use of silicone-based treatments to minimize keloid formation.

Request for a detailed insights report on Keloids pipeline insights @ https://www.delveinsight.com/report-store/keloids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

"Keloids Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Keloids Therapeutics Market.

Key Takeaways from the Keloids Pipeline Report

DelveInsight's Keloids pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for Keloids treatment.
Key Keloids companies such as Sirnaomics, Yuhan Pharmaceuticals, Lemonex Inc., CellionBioMed, and others are evaluating new drugs for Keloids to improve the treatment landscape.
Promising Keloids pipeline therapies in various stages of development include STP705, and others.

Recent breakthroughs in the Keloids Pipeline Segment:

A study published in Dermatologic Surgery evaluated the efficacy of combining intralesional bleomycin and triamcinolone for treating refractory keloids. Involving 33 patients, the study reported that 78.8% exhibited excellent response (75%-100% flattening), while 21.2% showed fair response (25%-75% flattening). Side effects such as ulceration and hyperpigmentation were observed, indicating the need for careful monitoring during treatment.
Soliton, Inc. conducted a proof-of-concept trial using their RAP device, delivering rapid acoustic shockwaves as a non-invasive treatment for keloid and hypertrophic scars. After a single six-minute treatment, patients experienced an average reduction of over 27% in scar volume and nearly 17% in scar height at the six-week follow-up. Importantly, no treatment-related adverse events were reported, and patients experienced minimal pain during the procedure.

Keloids Pipeline Analysis
The report provides insights into:
The report provides detailed insights into the key companies that are developing therapies in the Keloids Market.
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Keloids treatment.
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Keloids market.

Download our free sample page report on Keloids pipeline insights @ https://www.delveinsight.com/sample-request/keloids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Keloids Emerging Drugs

STP705: Sirnaomics

Keloids Companies

More than five key companies are actively developing therapies for keloids. Among them, Sirnaomics, Inc. has a drug candidate in Phase II clinical trials, representing the most advanced stage of development in this segment.

DelveInsight's report covers around 5+ products under different phases of clinical development like

Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates

Keloids pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

Intravenous
Subcutaneous
Oral
Intramuscular

Keloids Products have been categorized under various Molecule types such as

Monoclonal antibody
Small molecule
Peptide

Download Sample Pages to Get an in-depth Assessment of the Emerging Keloids Therapies and Key Companies: Keloids Clinical Trials and advancements @ https://www.delveinsight.com/report-store/keloids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Keloids Pipeline Therapeutic Assessment
• Keloids Assessment by Product Type
• Keloids By Stage
• Keloids Assessment by Route of Administration
• Keloids Assessment by Molecule Type

Download Keloids Sample report to know in detail about the Keloids treatment market @ Keloids Therapeutic Assessment @ https://www.delveinsight.com/sample-request/keloids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Table of Content

1. Report Introduction
2. Executive Summary
3. Keloids Current Treatment Patterns
4. Keloids - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Keloids Late-Stage Products (Phase-III)
7. Keloids Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Keloids Discontinued Products
13. Keloids Product Profiles
14. Keloids Key Companies
15. Keloids Key Products
16. Dormant and Discontinued Products
17. Keloids Unmet Needs
18. Keloids Future Perspectives
19. Keloids Analyst Review
20. Appendix
21. Report Methodology

Request the Sample PDF to Get Detailed Insights About the Keloids Pipeline Reports Offerings: https://www.delveinsight.com/report-store/keloids-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Contact Info:
Kritika Rehani
krehani@delveinsight.com
info@delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.